The Science
Thirty years across genomics, bioinformatics, precision diagnostics and clinical translation. The foundation on which everything else rests.
67+ publications · 9,550+ citations · h-index 39
Explore the science →José Pereira Leal
Barcelona · Lisbon · Doha
Scientist, entrepreneur, writer and institution-builder.
I work at the intersection of science, healthcare, innovation, capital and policy.
Over the last three decades, my work has spanned academic research, clinical diagnostics, venture creation, health-innovation ecosystems and translational medicine.
The thread connecting these activities is a single question: How do ideas become impact?
A connected practice
Four dimensions of the work
Science, enterprise, public argument and imagination are not separate identities. They are different ways of examining how knowledge, institutions and people change what becomes possible.
The Bridge
Building connections between ideas and implementation, science and society, Europe and the Gulf, and the institutions that transform innovation into impact.
Explore the work →The Voice
Books, essays and frameworks used to organise experience, test arguments and explore diagnostics, sovereignty, innovation and the future.
Explore the writing →The Source
Fiction under the name J.P. Leal, and a wider curiosity across science, philosophy, spirituality and the full range of human experience.
Explore wider explorations →In focus
Selected work
Current and recent work across diagnostics development, institutional capability and writing.
Framework · Version 1.0Diagnostics Readiness Levels
A multidimensional framework for evaluating diagnostic and biomarker development from concept to adoption.
Explore →Book in progressThe Import ConditionDiagnostics, sovereignty and the Gulf’s industrial moment.
Explore →Published bookPrecision Diagnostics: A Founder’s JourneyWhat it takes to build diagnostics at the frontiers of medicine.
Explore →Europe and the Gulf
Working across disciplines, institutions and geographies.
I work selectively with people and organisations confronting consequential questions in diagnostics, precision medicine, innovation and health infrastructure.